Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Oncol
    June 2018
  1. SUGITA S, Enokida H, Yoshino H, Miyamoto K, et al
    HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Int J Oncol. 2018 Jun 11. doi: 10.3892/ijo.2018.4435.
    >> Share

    May 2018
  2. ZHANG L, Yang G, Zhang R, Dong L, et al
    Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.
    Int J Oncol. 2018 May 30. doi: 10.3892/ijo.2018.4423.
    >> Share

    April 2018
  3. YANG X, Yin H, Zhang Y, Li X, et al
    Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1alpha activation.
    Int J Oncol. 2018 Apr 24. doi: 10.3892/ijo.2018.4376.
    >> Share

    March 2018
  4. LI C, Liu J, Zhang Q, Cui K, et al
    Upregulation of Ecadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting beta-catenin/TCF target genes.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4346.
    >> Share

  5. LIU M, Chen Y, Huang B, Mao S, et al
    Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.
    Int J Oncol. 2018 Mar 29. doi: 10.3892/ijo.2018.4342.
    >> Share

  6. LIU J, Zhai R, Zhao J, Kong F, et al
    Programmed cell death 4 overexpression enhances sensitivity to cisplatin via the JNK/c-Jun signaling pathway in bladder cancer.
    Int J Oncol. 2018 Mar 5. doi: 10.3892/ijo.2018.4303.
    >> Share

    February 2018
  7. DU P, Ye L, Yang Y, Jiang WG, et al
    [Corrigendum] Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
    Int J Oncol. 2018 Feb 16. doi: 10.3892/ijo.2018.4277.
    >> Share

    November 2017
  8. KIM CJ, Terado T, Tambe Y, Mukaisho KI, et al
    Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4194.
    >> Share

  9. LV XY, Ma L, Chen JF, Yu R, et al
    Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
    Int J Oncol. 2017 Nov 7. doi: 10.3892/ijo.2017.4195.
    >> Share

    August 2017
  10. SUN Y, Guan Z, Zhao W, Jiang Y, et al
    Silibinin suppresses bladder cancer cell malignancy and chemoresistance in an NF-kappaB signal-dependent and signal-independent manner.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4089.
    >> Share

  11. YAMASHITA T, Higashi M, Momose S, Morozumi M, et al
    Nuclear expression of Y box binding-1 is important for resistance to chemotherapy including gemcitabine in TP53-mutated bladder cancer.
    Int J Oncol. 2017;51:579-586.
    >> Share

    May 2017
  12. XIONG Y, Huang F, Li X, Chen Z, et al
    CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Int J Oncol. 2017 May 17. doi: 10.3892/ijo.2017.4003.
    >> Share

  13. CHEN M, Lv JM, Ye JQ, Cui XG, et al
    Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.
    Int J Oncol. 2017 May 16. doi: 10.3892/ijo.2017.3997.
    >> Share

  14. KIM WT, Seo SP, Byun YJ, Kang HW, et al
    Garlic extract in bladder cancer prevention: Evidence from T24 bladder cancer cell xenograft model, tissue microarray, and gene network analysis.
    Int J Oncol. 2017 May 11. doi: 10.3892/ijo.2017.3993.
    >> Share

    April 2017
  15. FENG C, Sun P, Hu J, Feng H, et al
    miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Int J Oncol. 2017 Apr 20. doi: 10.3892/ijo.2017.3969.
    >> Share

  16. WANG CY, Xu ZB, Wang JP, Jiao Y, et al
    Rb deficiency accelerates progression of carcinoma of the urinary bladder in vivo and in vitro through inhibiting autophagy and apoptosis.
    Int J Oncol. 2017;50:1221-1232.
    >> Share

  17. LIU Z, Liu J, Zhao L, Geng H, et al
    Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
    Int J Oncol. 2017;50:1321-1329.
    >> Share

    March 2017
  18. HUSSAIN SA, Palmer DH, Syn WK, Sacco JJ, et al
    Gene expression profiling in bladder cancer identifies potential therapeutic targets.
    Int J Oncol. 2017 Mar 2. doi: 10.3892/ijo.2017.3893.
    >> Share

  19. HUSSAIN SA, Ansari J, Huddart R, Power DG, et al
    VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in t
    Int J Oncol. 2017;50:768-772.
    >> Share

    December 2016
  20. WANG JP, Jiao Y, Wang CY, Xu ZB, et al
    Rb knockdown accelerates bladder cancer progression through E2F3 activation.
    Int J Oncol. 2016 Dec 6. doi: 10.3892/ijo.2016.3791.
    >> Share

  21. CHEN L, Wang G, Luo Y, Wang Y, et al
    Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.
    Int J Oncol. 2016 Dec 5. doi: 10.3892/ijo.2016.3788.
    >> Share

    November 2016
  22. KAMEYAMA K, Horie K, Mizutani K, Kato T, et al
    Enzalutamide inhibits proliferation of gemcitabine-resistant bladder cancer cells with increased androgen receptor expression.
    Int J Oncol. 2016 Nov 24. doi: 10.3892/ijo.2016.3781.
    >> Share

    September 2016
  23. CHOI EO, Park C, Hwang HJ, Hong SH, et al
    Baicalein induces apoptosis via ROS-dependent activation of caspases in human bladder cancer 5637 cells.
    Int J Oncol. 2016;49:1009-18.
    >> Share

    April 2016
  24. LI QQ, Hao JJ, Zhang Z, Hsu I, et al
    Histone deacetylase inhibitor-induced cell death in bladder cancer is associated with chromatin modification and modifying protein expression: A proteomic approach.
    Int J Oncol. 2016 Apr 7. doi: 10.3892/ijo.2016.3478.
    >> Share

    March 2016
  25. ZHANG Y, Liu W, He W, Zhang Y, et al
    Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
    Int J Oncol. 2016 Mar 3. doi: 10.3892/ijo.2016.3415.
    >> Share

    January 2016
  26. XIE X, Pan J, Wei L, Wu S, et al
    Gene expression profiling of microRNAs associated with UCA1 in bladder cancer cells.
    Int J Oncol. 2016 Jan 25. doi: 10.3892/ijo.2016.3357.
    >> Share

    November 2015
  27. SUN Y, Guan Z, Liang L, Cheng Y, et al
    NF-kappaB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Int J Oncol. 2015 Nov 20. doi: 10.3892/ijo.2015.3256.
    >> Share

    September 2015
  28. HUANG YT, Cheng CC, Chiu TH, Lai PC, et al
    Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer.
    Int J Oncol. 2015 Sep 11. doi: 10.3892/ijo.2015.3155.
    >> Share

    August 2015
  29. ZHANG S, Zhang C, Liu W, Zheng W, et al
    MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Int J Oncol. 2015 Aug 7. doi: 10.3892/ijo.2015.3117.
    >> Share

    July 2015
  30. RIEGER C, Huebner D, Temme A, Wirth MP, et al
    Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Int J Oncol. 2015 Jul 20. doi: 10.3892/ijo.2015.3096.
    >> Share

    June 2015
  31. GAO Y, Guan Z, Chen J, Xie H, et al
    CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Int J Oncol. 2015 Jun 9. doi: 10.3892/ijo.2015.3041.
    >> Share

    May 2015
  32. MATSUSHIMA M, Kikuchi E, Matsumoto K, Hattori S, et al
    Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
    Int J Oncol. 2015 May 11. doi: 10.3892/ijo.2015.2995.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016